down arrow

IDEXX Laboratories, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45168D1046
  • NASDAQ: IDXX
USD
522.02
0.52 (0.1%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,216.59
1,140.82
1,090.58
1,105.24
1,109.46
998.43
954.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,216.59
1,140.82
1,090.58
1,105.24
1,109.46
998.43
954.29
Raw Material Cost
437.06
417.93
431.06
419.92
415.90
371.30
386.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.46
8.95
10.52
11.73
12.06
8.39
8.47
Selling and Distribution Expenses
288.09
294.37
275.68
265.09
259.79
247.78
251.25
Other Expenses
5.40
5.68
5.63
5.17
4.98
5.07
4.93
Total Expenditure (Excl Depreciation)
790.59
778.08
773.57
748.43
737.59
678.15
695.49
Operating Profit (PBDIT) excl Other Income
426
362.70000000000005
317
356.8
371.9
320.3
258.8
Other Income
0.35
0.65
-0.61
-1.11
2.14
-2.21
5.56
Operating Profit (PBDIT)
467.40
401.07
355.12
392.33
409.78
352.14
298.06
Interest
11.46
8.95
10.52
11.73
12.06
8.39
8.47
Exceptional Items
2.33
1.00
1.10
0.80
0.40
0.40
0.50
Gross Profit (PBDT)
779.52
722.89
659.51
685.32
693.55
627.12
567.77
Depreciation
41.05
37.68
38.72
36.63
35.77
34.06
33.71
Profit Before Tax
417.22
355.44
306.98
344.77
362.35
310.08
256.39
Tax
78.81
77.00
58.79
70.16
68.36
67.41
40.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
338.41
278.45
248.19
274.61
293.99
242.68
216.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
338.41
278.45
248.19
274.61
293.99
242.68
216.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
338.41
278.45
248.19
274.61
293.99
242.68
216.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
1,612.58
1,556.10
1,605.38
1,561.19
1,458.83
1,448.01
1,595.31
Earnings per share (EPS)
4.27
3.47
3.08
3.4
3.63
2.96
2.62
Diluted Earnings per share
4.27
3.47
3.08
3.4
3.63
2.96
2.62
Operating Profit Margin (Excl OI)
35.02%
31.8%
29.07%
32.28%
33.52%
32.08%
27.12%
Gross Profit Margin
37.67%
34.46%
31.7%
34.51%
35.88%
34.47%
30.4%
PAT Margin
27.82%
24.41%
22.76%
24.85%
26.5%
24.31%
22.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 9.65% vs 10.55% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 15.10% vs 44.61% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 14.60% vs 36.92% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -4.96% vs 27.37% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of IDEXX Laboratories, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,216.59
1,308.40
-91.81
-7.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,216.59
1,308.40
-91.81
-7.02%
Raw Material Cost
437.06
478.40
-41.34
-8.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.46
3.00
8.46
282.00%
Selling and Distribution Expenses
288.09
358.70
-70.61
-19.68%
Other Expenses
5.40
15.00
-9.60
-64.00%
Total Expenditure (Excl Depreciation)
790.59
990.10
-199.51
-20.15%
Operating Profit (PBDIT) excl Other Income
426.00
318.30
107.70
33.84%
Other Income
0.35
2.20
-1.85
-84.09%
Operating Profit (PBDIT)
467.40
388.70
78.70
20.25%
Interest
11.46
3.00
8.46
282.00%
Exceptional Items
2.33
0.00
2.33
Gross Profit (PBDT)
779.52
830.00
-50.48
-6.08%
Depreciation
41.05
68.20
-27.15
-39.81%
Profit Before Tax
417.22
317.50
99.72
31.41%
Tax
78.81
68.40
10.41
15.22%
Provisions and contingencies
0
0
0.00
Profit After Tax
338.41
249.10
89.31
35.85%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
338.41
249.10
89.31
35.85%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
338.41
249.10
89.31
35.85%
Equity Capital
0
0
0.00
Face Value
0.10
0.00
0.00
Reserves
1,612.58
2,621.40
-1,008.82
-38.48%
Earnings per share (EPS)
4.27
0.64
3.63
567.19%
Diluted Earnings per share
4.27
0.64
3.63
567.19%
Operating Profit Margin (Excl OI)
35.02%
24.33%
0.00
10.69%
Gross Profit Margin
37.67%
29.48%
0.00
8.19%
PAT Margin
27.82%
19.04%
0.00
8.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 121.66 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 6.64% vs 4.60% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 9.65% vs 10.55% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 33.84 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 21.55% vs 12.17% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.10% vs 44.61% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.71 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 16.66% vs 12.57% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 14.60% vs 36.92% in Jun 2025

Quarterly - Interest
Interest 1.15 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 29.21% vs -15.24% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -4.96% vs 27.37% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.02%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading